Laura Howes - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Laura Howes's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Laura Howes
Verified
European Correspondent, C and EN
Heidelberg
Beats
Social Media Analytics SEOData
Open to all topics.
Content
By Laura Howes Verified| C and EN Verified At the American Chemical Society Spring 2025 meeting on Tuesday, Ed Griffen of MedChemica disclosed the structure of a pancoronavirus antiviral that targets the main protease (M pro ) of the two different coronaviruses that cause Middle East respiratory syndrome (MERS) and COVID-19. The antiviral, ASAP-0017445, was presented as part of a digital session titled "Developing Countermeasures for Viruses of Pandemic Potential" organized by the Division of Medicinal Chemistry of the ACS.
By Laura Howes Verified| C and EN Verified Oslo-based Tribune Therapeutics has raised $40 million to advance its way of inhibiting the formation of scar tissue in disease. The cash from investors including LifeArc Ventures, Novo Holdings, and HealthCap will allow the biotechnology firm to start toxicology work on its pan-antifibrotic lead candidate and to advance other potential treatments.
By Laura Howes Verified| C and EN Verified At the American Chemical Society Spring 2025 meeting on Tuesday, Ed Griffen of MedChemica disclosed the structure of a pancoronavirus antiviral that targets the main protease (M pro ) of the two different coronaviruses that cause Middle East respiratory syndrome (MERS) and COVID-19. The antiviral, ASAP-0017445, was presented as part of a digital session titled "Developing Countermeasures for Viruses of Pandemic Potential" organized by the Division of Medicinal Chemistry of the ACS.
Company Info
C and EN
England, United Kingdom